Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
OSIRIS THERAPEUTICS, INC.
| Metric | OSIRIS THERAPEUTICS, INC. Healthcare |
|---|---|
| Quality Score | 68 / 100 |
| Revenue (latest) | $143M |
| Net income (latest) | $37M |
| Operating margin | 6.9% |
| Net margin | 25.8% |
| Return on equity | 47.0% |
| Return on assets | 36.4% |
| Return on capital (ROCE) | 12.2% |
| Debt / equity | 0.29× |
| Revenue growth (YoY) | 20.5% |
| Altman Z″ (distress) | 0.85 |
| Accruals / assets | 29.2% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.